EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sight Sciences's Enterprise Value is $184.37 Mil.
Sight Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $-40.37 Mil. Therefore, Sight Sciences's EV-to-FCF for today is -4.57.
The historical rank and industry rank for Sight Sciences's EV-to-FCF or its related term are showing as below:
SGHT'
s EV-to-FCF Range Over the Past 10 Years
Min: -37.24 Med: -4.32 Max: 0.65
Current: -4.52
During the past 6 years, the highest EV-to-FCF of Sight Sciences was 0.65. The lowest was -37.24. And the median was -4.32.
SGHT's EV-to-FCF is ranked worse than 100% of 362
companies
in the Medical Devices & Instruments industry
Industry Median: 27.855
vs SGHT: -4.52
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for Sight Sciences's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sight Sciences's EV-to-FCF
For the Medical Devices subindustry, Sight Sciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sight Sciences's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sight Sciences's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Sight Sciences's EV-to-FCF falls into.
Sight Sciences's current Enterprise Value is $184.37 Mil.
Sight Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-40.37 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sight Sciences (NAS:SGHT) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Sight Sciences's PE Ratio for today is calculated as:
Sight Sciences's share price for today is $5.32.
Sight Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.120.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Sight Sciences EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Sight Sciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Sight Sciences (Sight Sciences) Business Description
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SGHT has been successfully added to your 